Lv4
730 积分 2022-07-17 加入
Decoding ferroptosis for cancer therapy
4天前
已完结
Design and Development of DNA Damage Chemical Inducers of Proximity for Targeted Cancer Therapy
1个月前
已完结
Targeting the N-terminal domain of the androgen receptor: The effective approach in therapy of CRPC
1个月前
已完结
First-in-Class Small Molecule to Inhibit CYP11A1 and Steroid Hormone Biosynthesis
2个月前
已完结
Targeting the Nuclear Receptor-Binding SET Domain Family of Histone Lysine Methyltransferases for Cancer Therapy: Recent Progress and Perspectives
3个月前
已完结
Recent advances in nuclear receptor-binding SET domain 2 (NSD2) inhibitors: An update and perspectives
3个月前
已完结
NSD2 inhibitors rewire chromatin to treat lung and pancreatic cancers
3个月前
已完结
Phase 1 study of HP518, a PROTAC AR degrader in patients with mCRPC: results on safety, pharmacokinetics, and anti-tumor activity
4个月前
已完结
Discovery of a Small-Molecule Inhibitor Targeting the Androgen Receptor N-Terminal Domain for Castration-Resistant Prostate Cancer
4个月前
已完结
Olaparib plus abiraterone versus placebo plus abiraterone in metastatic castration-resistant prostate cancer (PROpel): final prespecified overall survival results of a randomised, double-blind, phase 3 trial
6个月前
已完结
皖公网安备34019202002308
